Both in Surgical Instruments
Lucid Diagnostics vs Pulmonx
Over the past year LUCD returned −59.9% and LUNG returned +64.5%; their daily moves had a correlation of 0.13.
LUCD −59.9% LUNG +64.5%Growth of $1, one year, split-adjusted
| Metric | LUCD | LUNG |
|---|---|---|
| Price | $0.4451 | $2.83 |
| Market cap | $85.0M | $121.5M |
| Today | +8.83% | +4.04% |
| 1 month | −25.8% | +59.0% |
| 6 months | −58.8% | +119.4% |
| Year to date | −59.2% | +28.1% |
| 1 year | −63.2% | +54.6% |
| Revenue growth (YoY) | +26.7% | −4.6% |
| Gross margin | 2.0% | 78.0% |
| Net margin | −998.3% | −44.3% |
| P/E (TTM) | — | — |
| Price / sales | 15.6× | 1.4× |
| Net cash | $9.9M | $18.3M |
| Dividend yield | — | — |
| Volatility (60d) | 109.9% | 96.9% |
| Short % of float | 8.7% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).